A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4

NCT01057667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: RO5024048
DRUG: Ribavirin [Copegus]
DRUG: peginterferon alfa-2a [Pegasys]

Sponsor

Hoffmann-La Roche